In a clinical trial, patients receiving the diabetes drug liraglutide, which contains a satiety hormone, had double the chance of shedding blubber than those prescribed the anti-obesity drug Orlistat which goes under the trade name of Xenical. Liraglutide is good at curbing hunger according to a report written by an expert who just happened to be paid by the manufacturers of the drug. At a whopping £500 for a six months course, the drug is likely to be unpopular, as it has to be injected daily. It works by producing more insulin in the body and telling the brain to stop eating.
The search is on for the most effective way of treating obesity and its accompanying health risks: in the UK alone it's estimated that more than half of all men and women will end up obese if current trends continue. And whichever pharmaceutical giant comes up with a magic pill to shed the pounds stands to make billions. It’s also a reason why other cheaper and more effective treatments aren’t considered more often such as taking more exercise, wiring up jaws, hypnotising big eaters or fitting gastric bands.
Of course, there is a very large test group of patients who have already been involved in top-secret clinical trials being conducted by the NHS. A treatment has been developed that offers a 100% success rate in reducing obesity and has virtually no side effects. It simply involves physical restraining patients and feeding them a strict diet of NHS food.